JMIR Formative Research

View query in Help articles search

Field

e.g. mhealth

Operator

Field

Criteria

e.g. John Smith or 0000-0001-6479-5330

Exact Match for Criteria

Yes No

Search Results (1 to 10 of 7104 Results)

Download search results: CSV END BibTex RIS

Sort by:

Experiences Receiving and Delivering Virtual Health Care For Women: Qualitative Evidence Synthesis

Karen M Goldstein, Sharron Rushton, Allison A Lewinski, Abigail Shapiro, Tiera Lanford-Davey, Jessica N Coleman, Neetu Chawla, Dhara B Patel, Katherine Van Loon, Megan Shepherd-Banigan, Catherine Sims, Sarah Cantrell, Susan Alton Dailey, Jennifer M Gierisch

J Med Internet Res 2025;27:e68314

Download Citation: END BibTex RIS

Download PDF Download XML

A Deep Learning–Enabled Workflow to Estimate Real-World Progression-Free Survival in Patients With Metastatic Breast Cancer: Study Using Deidentified Electronic Health Records

Reference 16: Building a best-in-class automated de-identification tool for electronic health records

Gowtham Varma, Rohit Kumar Yenukoti, Praveen Kumar M, Bandlamudi Sai Ashrit, K Purushotham, C Subash, Sunil Kumar Ravi, Verghese Kurien, Avinash Aman, Mithun Manoharan, Shashank Jaiswal, Akash Anand, Rakesh Barve, Viswanathan Thiagarajan, Patrick Lenehan, Scott A Soefje, Venky Soundararajan

JMIR Cancer 2025;11:e64697

Download Citation: END BibTex RIS

Download PDF Download XML

Mobile Therapeutic Attention for Treatment-Resistant Schizophrenia (m-RESIST) Solution for Improving Clinical and Functional Outcomes in Treatment-Resistant Schizophrenia: Prospective, Multicenter Efficacy Study

In this study, the intervention involved patients and their caregivers, and the main actors involved in the deployment of the m-RESIST solution were psychiatrists, psychologists, and case managers. The key aim of the m-RESIST solution was to engage patients with TRS, together with their caregivers, in therapeutic processes, and empower them to enable their self-management.

Jussi Seppälä, Eva Grasa, Anna Alonso-Solis, Alexandra Roldan-Bejarano, Marianne Haapea, Matti Isohanni, Jouko Miettunen, Johanna Caro Mendivelso, Cari Almazán, Katya Rubinstein, Asaf Caspi, Zolt Unoka, Kinga Farkas, Elisenda Reixach, Jesus Berdun, Judith Usall, Susana Ochoa, Iluminada Corripio, Erika Jääskeläinen, m-Resist Group

JMIR Hum Factors 2025;12:e67659

Download Citation: END BibTex RIS

Download PDF Download XML

Developing the MyCancerGene Digital Health Portal to Improve Patients’ Understanding of Germline Cancer Genetic Test Results: Development, User, and Usability Testing Study

(Yes/No).” e“Do you think there would be any challenges with and/or barriers to using a Genetic Health Portal?” f“How likely is it that you would use a Genetic Health Portal?” g Indicates somewhat or very likely on a 5-point Likert scale. Table 4 presents patient feedback on why a GHP might be considered helpful, based on responses from 224 participants.

Phillip Trieu, Dominique Fetzer, Briana McLeod, Kathryn Schweickert, Lauren Gutstein, Brian Egleston, Susan Domchek, Linda Fleisher, Lynne Wagner, Kuang-Yi Wen, Cara Cacioppo, Jessica E Ebrahimzadeh, Dana Falcone, Claire Langer, Elisabeth Wood, Kelsey Karpink, Shelby Posen, Enida Selmani, Angela R Bradbury